Skip to search formSkip to main contentSkip to account menu

lixazinone

Known as: Butanamide, N-cyclohexyl-N-methyl-4-((1,2,3,5-tetrahydro-2-oxoimidazo(2,1-b)quinazolin-7-yl)oxy)-, N-cyclohexyl-N-methyl-4-(7-oxy-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolin-2-one)butyramide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
  • T. Dousa
  • Cell Biochemistry and Biophysics
  • 2007
  • Corpus ID: 24598876
Mesangial cells (MC) of renal glomeruli respond to immune-inflammatory injury by accelerated proliferation and generation of… 
Highly Cited
2000
Highly Cited
2000
The N-terminal portion of phosphodiesterase (PDE) 3 was arbitrarily divided into region 1 (amino acids 1–300), which contains a… 
Highly Cited
1997
Highly Cited
1997
cGMP enhances cAMP accumulation in platelets via cGMP-inhibited phosphodiesterase (PDE3) [Maurice and Haslam (1990) Mol… 
Highly Cited
1997
Highly Cited
1997
Some major pathobiologic processes in renal mesangial cells, elicited in response to immunoinflammatory stimuli, are modulated… 
1997
1997
We have used reverse transcriptase PCR, platelet mRNA and degenerate primers based on platelet peptide sequences, to amplify a… 
Highly Cited
1996
Highly Cited
1996
Excessive mesangial cell (MC) proliferation is a hallmark of many glomerulopathies. In our recent study on cultured rat MC… 
Highly Cited
1995
Highly Cited
1995
We studied interactions between the mitogen-activated protein kinase (MAPK) signalling pathway and cAMP-protein kinase (PKA… 
1988
1988
The cyclic AMP phosphodiesterase (cAMP PDE) inhibitor and cardiotonic agent lixazinone (N-cyclohexyl-N-methyl-4-[(1,2,3,5…